Literature DB >> 16634120

Measurement of changes in antihypertensive drug utilisation following primary care educational interventions.

Fiona E Horn1, John A Mandryk, Judith M Mackson, Sonia E Wutzke, Lynn M Weekes, Rob J Hyndman.   

Abstract

PURPOSE: To measure changes in drug utilisation following a national general practice education program aimed at improving prescribing for hypertension.
METHODS: A series of nationally implemented, multifaceted educational interventions using social marketing principles focusing on prescribing for hypertension, was commenced in October 1999, and repeated in September 2001 and August 2003. The target group was all primary care prescribers in Australia and interventions were both active (voluntary) and passive. Newsletter and prescribing feedback was mailed in October 1999, September 2001 (newsletter only) and August 2003. Approximately a third of general practitioners (GPs) in Australia undertook at least one active educational activity (clinical audit, educational visit or case study) during the period October 1999-April 2004. National dispensing data from 1996 to 2004 were analysed using time series methodology with a decay term for intervention effect, to assess trends in prescribing of various classes of antihypertensives. In particular, the program aimed to increase the prescribing of thiazide diuretics and beta blockers.
RESULTS: Consistent with key intervention messages, the program achieved an increase in low-dose thiazide and beta blocker prescribing. The rate of prescribing of low-dose thiazides doubled from 1.1 per 1000 consultations in October 1999 to 2.4 per 1000 in October 2003. Beta-blocker utilisation showed a more modest but significant increase over the time of the study, with the change in observed versus expected rate of prescribing increasing by 8% by April 2004. Therapeutic options for treating hypertension changed markedly in the time of the study with the advent of ACE inhibitor/Angiotensin II receptor antagonists and thiazide combination products. It is important, therefore, to interpret the results in light of these changes.
CONCLUSION: A national education program aimed at GPs was successful in improving prescribing for hypertension. Lessons learned will be applied in evaluation of future NPS programs and are also applicable to analysis of other interventions aimed at influencing prescribing behaviour. (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16634120     DOI: 10.1002/pds.1243

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  7 in total

1.  Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors use in Australia and Nova Scotia (Canada).

Authors:  Nadia Barozzi; Ingrid Sketris; Charmaine Cooke; Susan Tett
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

2.  Antihypertensive use before and after initiation of fixed-dose combination products in Australia: a retrospective study.

Authors:  Svetla Gadzhanova; Jenni Ilomäki; Elizabeth E Roughead
Journal:  Int J Clin Pharm       Date:  2013-05-16

3.  Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia.

Authors:  Jianyun Wu; Scott Dickinson; Zain Elgebaly; Suzanne Blogg; Aine Heaney; Yien Soo; Benjamin Daniels; Lynn Weekes
Journal:  BMC Fam Pract       Date:  2020-05-09       Impact factor: 2.497

4.  Effect of an educational intervention on the number potential drug-drug interactions.

Authors:  Aigul Z Mussina; Gaziza A Smagulova; Galina V Veklenko; Bibigul B Tleumagambetova; Nazgul A Seitmaganbetova; Aigul A Zhaubatyrova; Lazzat M Zhamaliyeva
Journal:  Saudi Pharm J       Date:  2019-04-08       Impact factor: 4.330

5.  Prescribing Data in General Practice Demonstration (PDGPD) project--a cluster randomised controlled trial of a quality improvement intervention to achieve better prescribing for chronic heart failure and hypertension.

Authors:  Margaret Williamson; Magnolia Cardona-Morrell; Jeffrey D Elliott; James F Reeve; Nigel P Stocks; Jon Emery; Judith M Mackson; Jane M Gunn
Journal:  BMC Health Serv Res       Date:  2012-08-23       Impact factor: 2.655

6.  Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study.

Authors:  Brett D Montgomery; Peter R Mansfield; Geoffrey K Spurling; Alison M Ward
Journal:  BMC Public Health       Date:  2008-05-20       Impact factor: 3.295

7.  Relationship between antimicrobial-resistance programs and antibiotic dispensing for upper respiratory tract infection: An analysis of Australian data between 2004 and 2015.

Authors:  Jianyun Wu; Daniel Taylor; Ludmila Ovchinikova; Aine Heaney; Tessa Morgan; Jonathan Dartnell; Rachel Holbrook; Lauren Humphreys; Lynn Weekes; Suzanne Blogg
Journal:  J Int Med Res       Date:  2018-01-14       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.